Shell Asset Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
DSCM
SFM
AC
SBH
BAM
Shell Asset Management's ANGO Position: Q3 2025 in Review
Shell Asset Management sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 6,169 shares — an estimated $61K sold.
Shell Asset Management first reported a position in ANGO in Q1 2019 and held it in 25 quarters. The position peaked at $827K in Q2 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.
- Shell Asset Management reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
- Shell Asset Management sold 6,169 AngioDynamics shares in Q3 2025, an estimated $61K.
- Shell Asset Management first reported a position in AngioDynamics in Q1 2019 and held it in 25 quarters.
- Shell Asset Management's AngioDynamics position peaked at $827K in Q2 2021.
- 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.